Today's Stock Price Targets and Analyst Ratings

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
AAPL Apple	Reiterated by	Moffett Nathanson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$316.41 -1.1%	$304.00	Neutral
AAPL Apple	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Laura Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$316.41 -1.1%		Hold
AAPL Apple	Reiterated by	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nicolas Cote-Colisson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$316.41 -1.1%	$366.00	Buy
ABBV AbbVie	Reiterated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Geoff Meacham Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$250.60 -2.3%		Buy
ABNB Airbnb	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Colin Sebastian Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$175.27 -3.7%	$175.00 ➝ $200.00	Outperform
ABNB Airbnb	Upgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Josh Beck Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$175.27 -3.7%	$200.00	Market Perform ➝ Outperform
ABSI Absci	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kambiz Yazdi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.99 +1.9%	$13.00 ➝ $16.00	Buy
ABSI Absci	Target Set by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kambiz Yazdi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.99 +1.9%	$15.00
ABT Abbott Laboratories	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Jennings Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$106.13 -2.0%	$135.00	Buy
ADBE Adobe	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$257.61 -3.3%		Market Perform
Here’s the stock symbol I’ve promised (Ad) Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required. Get the stock name and ticker symbol free of charge today
ADBE Adobe	Target Set by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregg Moskowitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$257.61 -3.3%	$260.00
ADI Analog Devices	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Buchalter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$363.34 +0.3%	$460.00	Buy
ADI Analog Devices	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Prisco Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$363.34 +0.3%		Overweight
ADI Analog Devices	Target Set by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$363.34 +0.3%	$460.00
AHEXY Adecco	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$14.27 -4.1%		Underweight
AKBA Akebia Therapeutics	Initiated by	Westpark Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ed Arce Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$0.98 +0.3%	$4.50	Buy
ALNY Alnylam Pharmaceuticals	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Faisal Khurshid Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$260.66 -2.0%	$230.00 ➝ $260.00	Hold
ALV Autoliv	Downgraded by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Itay Michaeli Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$120.09 -4.1%	$148.00 ➝ $137.00	Buy ➝ Hold
AME AMETEK	Initiated by	Vertical Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$239.81 +0.9%	$255.00	Buy
AMGN Amgen	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Carter Gould Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$393.70 -10.0%	$400.00	Neutral
AMGN Amgen	Downgraded by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Evan David Seigerman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$393.70 -10.0%	$450.00	Outperform ➝ Market Perform
ANDG Andersen Group	Initiated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeffrey Silber Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$54.45 -3.2%	$58.00	Market Perform
ANL Adlai Nortye	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Pantginis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.79 +5.2%	$20.00	Buy
ANL Adlai Nortye	Target Set by	Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dev Prasad Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.79 +5.2%	$49.00
APH Amphenol	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Guy Hardwick Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$82.98 +0.2%	$200.00 ➝ $100.00	Overweight
APP AppLovin	Target Lowered by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Clark Lampen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$313.09 -2.3%	$408.00 ➝ $396.00	Buy
ARMK Aramark	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Chan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$57.82 +1.8%		Buy
ARWR Arrowhead Pharmaceuticals	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eric Joseph Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$85.65 -0.8%	$108.00	Buy
ATDRY Auto Trader Group	Upgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1.69 +1.5%		Hold ➝ Buy
AUB Atlantic Union Bankshares	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Wilczynski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$40.57 -0.8%	$49.00	Reduce
AUTO Auto Trader Group	Upgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 513.95 +1.7%	GBX 545 ➝ GBX 640	Buy
AWI Armstrong World Industries	Target Set by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Hughes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$171.19 -1.2%	$230.00
BBOX Tritax Big Box REIT	Target Lowered by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 152.43 -0.5%	GBX 196 ➝ GBX 188	Buy
BBY Best Buy	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Baker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$88.68 -1.8%	$95.00	Buy ➝ Neutral
BESIY BE Semiconductor Industries	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$226.51 -0.7%		Overweight
BHVN Biohaven	Downgraded by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Leonid Timashev Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.99 -4.5%	$23.00 ➝ $19.00	Outperform ➝ Sector Perform
BIOA BioAge Labs	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Shrader Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.46 -1.4%	$40.00	Buy
BLTE Belite Bio	Target Set by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$196.31 +1.4%	$245.00
BMY Bloomsbury Publishing	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 619 -1.4%	GBX 825	Buy
BNTX BioNTech	Downgraded by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Evan David Seigerman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$99.54 -4.1%	$128.00 ➝ $105.00	Outperform ➝ Market Perform
Forget SpaceX, Elon Is Now Powering the Next Hot IPO (Ad) Elon Musk is backing a new AI startup that's quietly growing faster than Tesla, SpaceX, and reportedly 23 times faster than Nvidia, according to Jeff Brown of Brownstone Research. The company recently filed paperwork for what could become the next major IPO on Wall Street. Investors can explore how to claim a pre-IPO stake for as little as $50 before shares go public. See the startup's name and pre-IPO details now
BTBT Bit Digital	Initiated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Colonnese Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.73 +5.2%	$4.00	Buy
CBC Central Bancompany	Downgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$32.97 +1.0%	$36.00	Overweight ➝ Equal Weight
CBSH Commerce Bancshares	Upgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$58.42 +0.1%	$76.00	Positive ➝ Overweight
CCC Computacenter	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 5,165 -7.8%	GBX 6,500	Buy
CDW CDW	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tim Long Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$144.72 -5.0%	$123.00 ➝ $150.00	Equal Weight
CFG Citizens Financial Group	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Kenny Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$70.39 -0.6%	$90.00
CFR Cullen/Frost Bankers	Upgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$164.41 +1.1%	$200.00	Underweight ➝ Overweight
CHRW C.H. Robinson Worldwide	Upgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ariel Rosa Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$151.16 +2.4%	$196.00 ➝ $185.00	Neutral ➝ Buy
CIZN Citizens	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$10.50 -1.6%		Market Outperform
CL Colgate-Palmolive	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nik Modi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$88.47 -0.3%	$104.00	Outperform
CLYM Climb Bio	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.81 +1.9%	$24.00 ➝ $30.00	Buy
CLYM Climb Bio	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Leland Gershell Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.81 +1.9%	$25.00	Outperform
CMS CMS Energy	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Thalacker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$69.08 +0.9%	$82.00 ➝ $77.00	Outperform
COR Cencora	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Halsted Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$327.43 -1.1%	$330.00	Sector Perform
COST Costco Wholesale	Upgraded by	Freedom Broker Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Georgy Vashchenko Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$908.20 -0.8%	$1,030.00	Hold ➝ Buy
CPB Campbell's	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matt Curtis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.46 +0.4%	$20.00	Neutral
CPT Camden Property Trust	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vikram Malhorta Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$105.49 -0.2%	$125.00 ➝ $116.00	Outperform
CRCL Circle Internet Group	Initiated by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vasundhara Govil Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$97.54 -4.4%	$105.00	Market Perform
CUBI Customers Bancorp	Downgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Wilczynski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$79.33 -2.1%	$89.00	Equal Weight ➝ Underweight
CUZ Cousins Properties	Target Set by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vikram Malhotra Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$28.43 -2.4%	$34.00
CVE Cenovus Energy	Upgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$33.07 +2.2%		Neutral ➝ Overweight
DASH DoorDash	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Ju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$200.13 -5.5%	$295.00	Buy
DCH American Axle & Manufacturing	Upgraded by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Itay Michaeli Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.16 +2.4%	$8.00 ➝ $10.00	Hold ➝ Buy
DG Dollar General	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Seth Sigman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$127.62 -4.2%	$148.00 ➝ $151.00	Overweight
DGX Quest Diagnostics	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Caliendo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$236.69 -0.2%	$245.00	Neutral
DINO HF Sinclair	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manav Gupta Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$108.25 +2.7%	$105.00 ➝ $126.00	Buy
DKNG DraftKings	Target Raised by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jordan Bender Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.73 -1.2%	$36.00 ➝ $37.00	Market Outperform
DKNG DraftKings	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Hardiman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.73 -1.2%		Market Outperform
DNLM Dunelm Group	Reiterated by	Shore Capital Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 760 -14.3%	GBX 1,000	Buy
DOCS Doximity	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$24.87 -5.6%	$27.00
DOO BRP	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Hardiman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$63.00 -6.4%		Buy
DYN Dyne Therapeutics	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$20.48 -15.7%		Strong-Buy
ECHO Echostar	Upgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Hodulik Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$93.30 +3.9%	$127.00 ➝ $150.00	Neutral ➝ Buy
EGAN eGain	Downgraded by	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$5.21 -10.8%	$7.00	Buy ➝ Neutral
EGAN eGain	Reiterated by	B Riley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$5.21 -10.8%		Neutral
ENGN enGene	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andres Y. Maldonado Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.89 +3.6%	$4.00	Buy
ENPH Enphase Energy	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Colin Rusch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$38.52 +5.9%		Outperform
EQBK Equity Bancshares	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nathan Race Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$50.89 -0.2%	$60.00	Overweight
EQIX Equinix	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brendan Lynch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,052.22 +1.6%	$1,130.00 ➝ $1,135.00	Equal Weight
ESS Essex Property Trust	Reiterated by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vikram Malhorta Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$278.56 0.0%	$308.00 ➝ $295.00	Outperform ➝ Neutral
ETSY Etsy	Target Raised by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Taylor Conrad Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.02 -5.9%	$67.00 ➝ $89.00	Buy
EVLV Evolv Technologies	Initiated by	LADENBURG THALM/SH SH Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Shervin Zand Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.10 +1.9%	$8.00	Buy
EWBC East West Bancorp	Upgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$130.14 -0.5%	$160.00	Equal Weight ➝ Overweight
EWG European Wealth Group	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 100	GBX 132	Buy
FCEL FuelCell Energy	Reiterated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$17.86 +19.5%		Sector Weight
FDS FactSet Research Systems	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manav Patnaik Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$291.06 -3.6%	$216.00 ➝ $250.00	Underweight
FDS FactSet Research Systems	Upgraded by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Nicholas Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$291.06 -3.6%		Market Perform ➝ Outperform
FDX FedEx	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Ossenbeck Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$316.49 -1.9%	$460.00 ➝ $400.00	Overweight
FDXF FedEx Freight	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Ossenbeck Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$129.75 +0.2%	$160.00	Overweight
FHN First Horizon	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$24.80 -0.6%	$30.00	Positive ➝ Equal Weight
This looks like plywood. It's not. (Ad) AI data centers have a power problem nobody likes to talk about. A single rack of computers can now use more electricity than an entire office building. One new chip, which looks more like a piece of plywood than a processor, delivers similar performance on a fraction of the power. Tech investing veteran George Gilder says that efficiency gap could decide who wins the next stage of AI. Gilder has identified three companies positioned around this power breakthrough, calling them the Trillion Dollar Triangle. See the three companies behind this AI power breakthrough now
FHN First Horizon	Target Set by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Kenny Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.80 -0.6%	$30.00
FLD Fold	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nathan Frankovitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$0.56 +4.0%		Overweight
FLG Flagstar Bank, National Association	Upgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.53 +0.0%	$17.00	Equal Weight ➝ Overweight
FLO Flowtech Fluidpower	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 67 -1.5%	GBX 100	Buy
FSJ James Fisher and Sons	Target Lowered by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 443 -2.6%	GBX 850 ➝ GBX 835	Buy
FSTA Fuller, Smith & Turner	Reiterated by	Shore Capital Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 716 -0.6%	GBX 1,000	Buy
GD General Dynamics	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gavin Parsons Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$356.20 -0.9%	$395.00 ➝ $408.00	Neutral
GENB Generate Biomedicines	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.92 -2.9%	$30.00	Buy
GENI Genius Sports	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Bazinet Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.39 -1.4%		Market Outperform
GFS GlobalFoundries	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	C.J. Muse Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$46.37 +2.6%		Overweight
GH Guardant Health	Initiated by	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jamie Clark Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$164.87 +2.1%	$203.00	Buy
GLW Corning	Initiated by	China Renaissance Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jack Zhou Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$168.48 +9.2%	$238.00	Hold ➝ Buy
GMR Gaming Realms	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 30 -0.7%	GBX 56	Buy
GPOR Gulfport Energy	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Zach Parham Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$179.01 -0.2%	$240.00 ➝ $194.00	Overweight ➝ Underweight
GRND Grindr	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nathan Feather Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.40 +1.0%		Overweight
HCA HCA Healthcare	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Hendrix Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$400.73 -1.1%	$435.00	Outperform
HCM HUTCHMED	Upgraded by	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$13.90 -1.3%		Hold ➝ Buy
HE Hawaiian Electric Industries	Initiated by	LADENBURG THALM/SH SH Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Fremont Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.97 -1.1%	$7.00	Sell
HIW Highwoods Properties	Target Set by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vikram Malhotra Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$30.46 -2.4%	$32.00
HNGE Hinge Health	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Grossman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$92.05 -0.3%	$115.00
HOG Harley-Davidson	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Hardiman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$27.43 -3.1%		Neutral
HOMB Home BancShares	Initiated by	Hovde Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward Najarian Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$30.04 -0.4%	$34.00	Outperform
HOOD Robinhood Markets	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ramsey El-Assal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$120.54 -1.3%	$115.00 ➝ $150.00	Overweight
HOOD Robinhood Markets	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Yaro Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$120.54 -1.3%	$124.00 ➝ $142.00	Buy
HOOD Robinhood Markets	Target Set by	Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Yaro Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$120.54 -1.3%	$142.00
HOOD Robinhood Markets	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Fannon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$120.54 -1.3%	$127.00 ➝ $140.00	Buy
HOOD Robinhood Markets	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gautam Chhugani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$120.54 -1.3%		Outperform
HYPD Hyperion DeFi	Target Raised by	Chardan Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James McIlree Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.56 +7.9%	$7.30 ➝ $8.45	Buy
IEX IDEX	Initiated by	Vertical Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$225.46 +0.8%	$250.00	Buy
IMB Imperial Brands	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 2,478 +0.2%	GBX 3,500	Buy
INTC Intel	Initiated by	Pivotal Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$105.64 +10.3%		Buy
INTC Intel	Upgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Timothy Arcuri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$105.64 +10.3%		Neutral ➝ Buy
INTC Intel	Initiated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Srini Pajjuri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$105.64 +10.3%		Sector Perform ➝ Outperform
INTC Intel	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Atif Malik Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$105.64 +10.3%		Buy
INTC Intel	Target Set by	Northland Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gus Richard Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$105.64 +10.3%	$120.00	Market Perform ➝ Outperform
IONS Ionis Pharmaceuticals	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Salveen Richter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.90 -3.8%	$69.00 ➝ $56.00	Neutral
IONS Ionis Pharmaceuticals	Target Set by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Lebowitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.90 -3.8%	$54.00
IONS Ionis Pharmaceuticals	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yaron Werber Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.90 -3.8%		Buy
IONS Ionis Pharmaceuticals	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Ulz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.90 -3.8%	$104.00	Overweight
IONS Ionis Pharmaceuticals	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gary Nachman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.90 -3.8%	$95.00 ➝ $85.00	Buy
IONS Ionis Pharmaceuticals	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mitchell Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.90 -3.8%	$115.00 ➝ $100.00	Buy
IPSEY IPSEN	Downgraded by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$45.91 -6.6%		Equal Weight ➝ Underweight
IRM Iron Mountain	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brendan Lynch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$118.26 +1.2%	$143.00 ➝ $144.00	Overweight
ISRG Intuitive Surgical	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Zimmerman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$349.84 -4.6%	$469.00	Buy
ITX Itaconix	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 210 +1.4%	GBX 375	Buy
JBL Jabil	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Delaney Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$311.61 +0.3%	$482.00 ➝ $375.00	Buy
JBTM JBT Marel	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Adam Seiden Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$117.36 -0.3%	$150.00	Overweight
KIGRY Kion Group	Upgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$14.02 +7.1%		Neutral ➝ Buy
KULR KULR Technology Group	Reiterated by	Litchfield Hills Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$2.51 -1.7%		Buy
KYCCF Keyence	Upgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$507.78 +0.7%		Buy
2:59 PM Friday. I make this trade. (Ad) Tim Sykes says he books gains almost every weekend using one simple move. The trade is placed around 2:59 pm on Friday, right before the market closes for the week. He breaks down the exact routine step by step for anyone curious how it works. Click here to learn how Tim Sykes places this weekly trade
LDOS Leidos	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gautam Khanna Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$130.01 -2.3%	$135.00	Hold
LHX L3Harris Technologies	Downgraded by	Melius Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$255.18 -0.5%		Buy ➝ Hold
LMT Lockheed Martin	Upgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gavin Parsons Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$536.68 +2.2%	$581.00 ➝ $674.00	Neutral ➝ Buy
MAA Mid-America Apartment Communities	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Haendel St. Juste Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$128.33 +0.0%	$152.00 ➝ $140.00	Outperform
MANH Manhattan Associates	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Guy Hardwick Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$205.43 -3.9%	$201.00 ➝ $239.00	Overweight
MBIN Merchants Bancorp	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$52.42 -0.5%	$65.00
MCG Mobico Group	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 23.55 +0.7%	GBX 35	Hold
MGY Magnolia Oil & Gas	Upgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Arun Jayaram Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$27.22 +1.5%	$32.00 ➝ $33.00	Neutral ➝ Overweight
MPC Marathon Petroleum	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manav Gupta Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$395.73 +1.8%	$321.00 ➝ $450.00	Buy
MRK Merck & Co., Inc.	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vamil Divan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$148.51 -1.2%	$146.00 ➝ $170.00	Buy
MSTR Strategy	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Vafi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$137.89 -3.4%	$175.00 ➝ $179.00	Buy
MTB M&T Bank	Upgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$240.86 +0.4%	$304.00	Equal Weight ➝ Overweight
NAMS NewAmsterdam Pharma	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lander Egaña Gorroño Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.45 -3.7%	$52.00	Buy
NBIX Neurocrine Biosciences	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Abrahams Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$155.96 +0.2%	$198.00	Outperform
NGLOY Anglo American	Initiated by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$29.27 +3.2%		Outperform
NOC Northrop Grumman	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gavin Parsons Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$516.18 +0.2%	$685.00 ➝ $704.00	Buy
NOW ServiceNow	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Allan Verkhovski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$134.11 -5.1%	$150.00 ➝ $170.00	Buy
NRIM Northrim BanCorp	Initiated by	Hovde Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brett Rabatin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.15 -1.1%	$30.00	Outperform
NTRA Natera	Initiated by	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jamie Clark Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$328.62 +0.1%	$385.00	Buy
NTRA Natera	Upgraded by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dan Leonard Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$328.62 +0.1%		Outperform ➝ Buy
NXPI NXP Semiconductors	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Prisco Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$225.18 -1.2%		Overweight
ODD ODDITY Tech	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan MacDonald Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.30 -3.2%		Hold
ODFL Old Dominion Freight Line	Upgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ariel Rosa Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$187.16 +0.7%	$231.00 ➝ $223.00	Neutral ➝ Buy
ONTO Onto Innovation	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Shane Brett Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$281.48 +5.0%	$360.00	Overweight
ORCL Oracle	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Schwartz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$162.77 +2.5%		Outperform
ORCL Oracle	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John DiFucci Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$162.77 +2.5%	$400.00	Buy
OUT OUTFRONT Media	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$29.11 +0.5%		Buy
OZK Bank OZK	Downgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$49.52 -1.8%	$56.00	Equal Weight ➝ Underweight
PANW Palo Alto Networks	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Ruykhaver Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$335.61 +0.7%	$425.00	Overweight
PATH UiPath	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yitchuin Wong Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.08 -7.3%	$23.00	Buy
PB Prosperity Bancshares	Downgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.13 -0.9%		Positive ➝ Underweight
PDFS PDF Solutions	Downgraded by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$49.17 +7.7%		Outperform
PDFS PDF Solutions	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$49.17 +7.7%	$62.00	Overweight
PGNY Progyny	Target Set by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Tanquilut Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$27.27 +5.1%	$33.00
PGNY Progyny	Target Raised by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Constantine Davides Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$27.27 +5.1%	$31.00 ➝ $33.00	Market Outperform
PGNY Progyny	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$27.27 +5.1%		Outperform
PHR Phreesia	Downgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Ransom Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.29 -5.9%		Outperform ➝ Market Perform
PHVS Pharvaris	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Laura Chico Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$38.58 +9.4%	$42.00	Outperform
PHVS Pharvaris	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick R. Trucchio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$38.58 +9.4%	$60.00	Buy
PL Planet Labs PBC	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edison Yu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.88 -1.3%	$28.00	Buy
PNFP Pinnacle Financial Partners	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$101.64 +0.6%	$137.00	Overweight
PRO Proservice Building Services Marketplace	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 2.40 -2.4%	GBX 5	Speculative Buy
PSX Phillips 66	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manav Gupta Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$258.53 +1.3%	$235.00 ➝ $300.00	Buy
PTON Peloton Interactive	Downgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$5.07 -6.2%	$4.50	Equal Weight ➝ Underweight
PTON Peloton Interactive	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Arpine Kocharyan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.07 -6.2%	$11.00 ➝ $10.00	Buy
RCUS Arcus Biosciences	Target Set by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Supawat Thongthip Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$29.27 -1.3%	$40.00
RF Regions Financial	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Betsy Graseck Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$30.24 -0.6%	$36.00
RGL Regional REIT	Reiterated by	Shore Capital Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 95 +0.6%		House Stock
RH RH	Target Set by	Telsey Advisory Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Cristina Fernandez Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$143.59 -3.0%	$140.00
RMV Rightmove	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 491.90 +1.2%	GBX 465	Hold
Here’s the stock symbol I’ve promised (Ad) Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required. Get the stock name and ticker symbol free of charge today
ROIV Roivant Sciences	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dennis Ding Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$41.98 +20.2%	$42.00 ➝ $52.00	Buy
RPRX Royalty Pharma	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Nedelcovych Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$60.02 -6.2%	$65.00 ➝ $68.00	Buy
RRC Range Resources	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Betty Jiang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.02 +0.1%	$40.00 ➝ $42.00	Equal Weight
RRC Range Resources	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Josh Silverstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.02 +0.1%	$42.00
SAIA Saia	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ariel Rosa Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$357.45 -0.1%		Buy
SAIC Science Applications International	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gavin Parsons Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$125.27 -1.2%	$93.00 ➝ $103.00	Sell
SBGSY Schneider Electric	Downgraded by	Santander Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$69.32 +3.8%		Outperform ➝ Neutral
SE SEA	Upgraded by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$113.14 +0.9%		Sector Perform ➝ Buy
SECZ Securitize	Initiated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Todaro Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.87 +6.1%	$11.00	Buy
SFNC Simmons First National	Downgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Wilczynski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.30 -1.6%	$26.00	Equal Weight ➝ Underweight
SG Sweetgreen	Upgraded by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Carril Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.83 -0.2%	$9.00	Sector Weight ➝ Overweight
SHAK Shake Shack	Initiated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Logan Reich Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$68.08 -1.9%	$89.00	Outperform
SHC Sotera Health	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Bednar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.69 -1.1%	$25.00	Overweight
SHOP Shopify	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Callahan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$134.70 -7.2%	$180.00	Overweight
SIG Signet Jewelers	Reiterated by	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeff Lick Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$80.64 -5.5%	$130.00	Overweight
SLG SL Green Realty	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brendan Lynch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$53.12 -4.4%	$52.00 ➝ $54.00	Equal Weight
SLG SL Green Realty	Target Set by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vikram Malhotra Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$53.12 -4.4%	$53.00
SMMT Summit Therapeutics	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$17.49 -0.6%	$33.00	Buy
SNN Smith & Nephew SNATS	Downgraded by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$27.86 -3.5%		Buy ➝ Neutral
SNX TD SYNNEX	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Guy Hardwick Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$261.05 -0.6%	$278.00 ➝ $287.00	Equal Weight
SPCX SpaceX	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ken Gawrelski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$153.83 +4.0%	$215.00 ➝ $212.00	Overweight
SPCX SpaceX	Initiated by	Pivotal Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeffrey Wlodarczak Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$153.83 +4.0%	$220.00	Buy
SPCX SpaceX	Target Set by	Pivotal Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeffrey Wlodarczak Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$153.83 +4.0%	$220.00
SPRY ARS Pharmaceuticals	Target Set by	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Roanna Ruiz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.43 -3.4%	$15.00
SRAD Sportradar Group	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Bazinet Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.77 -1.0%		Market Outperform
SRRK Scholar Rock	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andres Y. Maldonado Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$56.94 +2.9%	$65.00	Buy
SRRK Scholar Rock	Downgraded by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andres Y. Maldonado Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$56.94 +2.9%		Buy ➝ Neutral
STAN Standard Chartered	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 2,276.21 +0.3%	GBX 2,330 ➝ GBX 2,470	Overweight
STNG Scorpio Tankers	Reiterated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ken Hoexter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$81.29 -1.3%		Underperform
SYM Symbotic	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Guy Hardwick Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$43.77 +1.9%	$44.00 ➝ $38.00	Underweight
SYRE Spyre Therapeutics	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Julian Harrison Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$90.88 +2.1%	$121.00	Buy
TCRX TScan Therapeutics	Downgraded by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andres Y. Maldonado Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$0.35 -9.6%	$1.00	Buy ➝ Neutral
TEM Tempus AI	Initiated by	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jamie Clark Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$64.69 +0.1%	$67.00	Neutral
TEM Tempus AI	Initiated by	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jamie Clark Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$64.69 +0.1%	$67.00	Neutral
TH Target Hospitality	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Schneeberger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.30 +4.0%	$27.00	Outperform
TMDX TransMedics Group	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Jennings Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$88.26 -1.9%	$120.00	Buy
TPR Tapestry	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jay Sole Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$118.51 -3.0%		Buy
TRI Thomson Reuters	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manav Patnaik Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$99.27 -6.1%	$140.00 ➝ $130.00	Overweight
TRI Trifast	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 83.61 -3.2%	GBX 140	Buy
TTD Trade Desk	Reiterated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Justin Patterson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.15 -2.0%		Sector Weight
TTWO Take-Two Interactive Software	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Martin Yang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$215.39 +0.3%		Outperform
TYRA Tyra Biosciences	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Allison Bratzel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$28.08 -2.0%	$56.00	Overweight
UBER Uber Technologies	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Ju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$73.28 -3.3%		Buy
UBER Uber Technologies	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ygal Arounian Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$73.28 -3.3%	$91.00	Outperform
UDR United Dominion Realty Trust	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vikram Malhorta Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$36.17 -0.6%	$41.00 ➝ $39.00	Neutral
UMBF UMB Financial	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Wilczynski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$143.54 -0.2%	$190.00	Overweight
VEEV Veeva Systems	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stan Berenshteyn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$264.44 -3.9%	$330.00	Overweight
VERA Vera Therapeutics	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anupam Rama Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$35.02 -2.4%	$76.00 ➝ $83.00	Overweight
VLO Valero Energy	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manav Gupta Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$381.61 +2.9%	$355.00 ➝ $450.00	Buy
VMRK Vivmark Residential Common Shares of Beneficial Interest	Upgraded by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Haendel St. Juste Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$65.90 +0.8%	$70.00 ➝ $73.00	Neutral ➝ Outperform
VRNS Varonis Systems	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Ruykhaver Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$45.21 -1.9%		Overweight
VRSK Verisk Analytics	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manav Patnaik Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$176.78 -4.9%	$275.00 ➝ $225.00	Overweight
WLFC Willis Lease Finance	Target Set by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$59.17 +5.2%	$80.00
WLFC Willis Lease Finance	Initiated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Shannon Doherty Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$59.17 +5.2%	$80.00	Buy
WMMVY Wal-Mart de Mexico SAB de CV	Downgraded by	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$27.17 -2.7%	$42.00	Reduce
WPP WPP	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$25.09 -0.9%		Buy
XE X-Energy	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Osha Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.69 +5.5%	$57.00	Buy
XOM ExxonMobil	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manav Gupta Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$158.86 -0.4%		Buy
ZION Zions Bancorporation, N.A.	Downgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$68.56 -1.2%	$77.00	Overweight ➝ Underweight
ZS Zscaler	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Fatima Boolani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$163.23 -3.9%		Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 01:05 PM ET.

Stock Ratings and Recommendations: Understanding Analyst Ratings

Written by MarketBeat Staff

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stock Price Targets and Analyst Ratings